Viewing Study NCT05134194


Ignite Creation Date: 2025-12-25 @ 1:42 AM
Ignite Modification Date: 2025-12-25 @ 11:59 PM
Study NCT ID: NCT05134194
Status: TERMINATED
Last Update Posted: 2024-04-16
First Post: 2021-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module